News Propeller Health to bring smart inhaler tech to Novartis' Br... Partnership will focus on COPD in Europe.
News Stop obsessing about generic Advair, says GSK's Witty Growth elsewhere will soak up impact of US competitor, says Sir Andrew Witty.
News Novartis’ COPD combo show benefits in switching from establi... A new study suggests COPD patients experience improved lung function and breathlessness after direct switch from long-acting bronchodilators or steroid containing combination therapies to N
News Early filing gives GSK a boost in COPD Compelling data from FULFIL study puts GSK in pole position
Views & Analysis Digital Health Round-up – new President, new ideals? A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Propeller Health set for expansion with latest funding round $21.5 million in funding will be used to expand its existing roster of digitally-guided therapy solutions.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
